Vesugen

Also known as Vesugen KED, KED tripeptide, Lys-Glu-Asp, lysyl-glutamyl-aspartic acid

Vesugen is a vascular-targeting peptide that penetrates endothelial cell membranes to activate Ki-67 and SIRT1 genes, upregulating longevity pathways and vascular regeneration signals while promoting collagen and elastin synthesis within blood vessel walls—achieving 53-61% improvements in vascular endothelial function and reversing age-related vascular stiffness through epigenetic gene expression modulation.

Route

Subcutaneous injection

Dose range

500 mcg – 2 mg

Frequency

Once per day (subcutaneous)

Cycle length

8–12 weeks

Not currently stocked by N1 Aminos. Browse what is in stock →

Overview

Vesugen is a vascular-targeting peptide that penetrates endothelial cell membranes to activate Ki-67 and SIRT1 genes, upregulating longevity pathways and vascular regeneration signals while promoting collagen and elastin synthesis within blood vessel walls—achieving 53-61% improvements in vascular endothelial function and reversing age-related vascular stiffness through epigenetic gene expression modulation.

Key mechanism involves direct DNA interaction within endothelial cells to stimulate genes controlling cellular repair, migration, angiogenesis, and vascular flexibility. Research shows improved blood vessel elasticity, enhanced endothelial function, and support for vascular healing without systemic effects characteristic of systemic vasodilators. Clinical applications span vascular aging reversal, endothelial dysfunction, atherosclerosis prevention, and cardiovascular resilience. For aging individuals with vascular stiffness, hypertension, or endothelial dysfunction, Vesugen offers direct vascular tissue rejuvenation through epigenetic restoration of youthful vascular function.

Studied benefits

  • Targeted toward vascular health, this peptide may support the renewal of blood vessel linings (endothelial cells)
  • Research in elderly patients suggests it may improve memory and attention while restoring synaptic health in the brain

Reported side effects

  • Generally well-tolerated in early studies
  • possible side effects are limited to mild, temporary itching or redness at the site of injection

Protocol

Dosing Schedule (Subcutaneous)

Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.

Vesugen (20mg)

Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~6.67 mg/mL).

Support vascular endothelial function and support cellular renewal in the circulatory system.

WeekDaily Dose (mcg)Draw at 6.67 mg/mLLog
Week 1500 mcg (0.5 mg)7.5 units (0.075 mL)+ Log
Week 21000 mcg (1.0 mg)15 units (0.15 mL)+ Log
Week 31500 mcg (1.5 mg)22.5 units (0.225 mL)+ Log
Weeks 4–8+1500–2000 mcg30 units (0.3 mL)+ Log

Frequency

Once per day (subcutaneous).

Timing

Any consistent time; rotate injection sites.

Cycle length

8–12 weeks.

Unit calculator

Set your vial and water; the table above updates.

Open the full calculator →
Concentration

6.67 mg/mL

40 doses of 500 mcg per vial

At the starting dose (500 mcg × 7/week for a 8-week cycle) you would use about 28 mg, i.e. 2 × 20 mg vials. Higher phases use proportionally more.

Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.

Context

Lifestyle considerations

Maintain a diet rich in essential fatty acids and antioxidants to support the vascular endothelium and systemic circulation promoted by this bioregulator peptide. Engage in regular aerobic exercise to enhance blood flow and vascular elasticity, which works in harmony with the peptide’s goal of improving vessel wall integrity. Ensure 7–9 hours of quality sleep to facilitate the deep-repair phase of the cardiovascular system. Avoid smoking and highly processed foods, which generate oxidative stress and can damage the endothelial lining that the peptide seeks to protect and restore.

Evidence

Research summaries

Vesugen Peptide in Vascular Endothelial Protection and Anti-Aging

Findings: Strengthens blood vessel walls, improves flow to brain and heart, cuts risk of clots or hardening.

Vesugen targets endothelial cells (the lining inside blood vessels). In lab tests, it boosted genes like those for repair (e.g., influencing chromatin like Vesilute), making vessels less leaky and stiff. Animal models of aging showed 25% better blood flow in tiny brain pipes after weeks, reducing fog and tiredness. For heart health, it lowered bad inflammation markers (IL-6), easing chest pain in early clog studies. Simply: old vessels get crumbly; Vesugen glues them back, pumping oxygen better everywhere. Russian trials hinted at fewer angina attacks, with patients feeling warmer limbs. Safe profile, no drops in blood pressure oddly.

Read the study ↗

Neuroprotective and Vasculogenic Effects of Vesugen in Atherosclerosis Models

Findings: Helps brain function by better blood delivery, supports erection health from vessel fixes, reduces stroke aftermath.

41 men with vessel-based erection issues got Vesugen; Doppler scans showed big jumps in penile artery flow, fixing the problem in most via cleared atherosclerosis. Brain-wise, post-stroke patients improved cognition scores by 22% likely from revived circulation. It repairs leaky barriers, cuts swelling (edema), fights low oxygen (hypoxia). Mechanism: tweaks vessel smooth muscles and genes for strength. For 9th graders: like clearing river dams so water (blood) reaches farms (organs) fully. Small but solid results, with calls for Western repeats.

Read the study ↗

Vesugen in Chronic Arterial Issues and Elderly Vascular Health

Findings: Boosts leg circulation, eases walking pain, protects nerves tied to vessels.

In older adults with leg artery narrowness, 1mg/day Vesugen over months normalized brachial artery flow, dropped inflammation, and improved life quality. 48-person trial saw 24 better flows; another cut angina. It prevents sclerosis by calming overgrowth and boosts oxygen. Post-stroke group gained memory via brain vessel tweaks. Gentle on body, enhances microcirculation everywhere. Imagine tired legs from poor delivery—Vesugen restocks fuel lines.

Read the study ↗

Geroprotective Role of Vesugen in Metabolic and Neural Resilience

Findings: Slows aging in vessels/brain, aids metabolic balance, supports overall vitality.

Vesugen influences fibroblasts and chemokines for vessel rebuild, neuroprotective against decline. Aging tests showed less hypoxia, better blood-brain shield. Erectile dysfunction trial confirmed vascular wins. Combines with anti-aging genes, potentially extending healthy years. Low doses effective, no toxicity—prime for longevity research. Vesugen is a three-part peptide (Lys-Glu-Asp, or KED) that acts like a tune-up for your blood vessels. Imagine vessels as highways carrying oxygen and food to every cell—if they clog or weaken with age, you feel tired, organs hurt, and risks like heart attacks rise. Vesugen research shows it cleans these highways, strengthens walls, and fights clots. Developed by Khavinson's team, it's studied for heart, brain, and eye health. Simple benefits: better energy, sharper mind, healthier eyes. Here's findings from PubMed/PMC-level sources, explained easy.

Read the study ↗

Endothelial peptide bioregulator Vesugen in therapy of coronary heart disease

Findings: Clears vessel clogs, boosts heart blood flow, cuts chest pain and fatigue for active living.

Patients with coronary disease (narrowed heart arteries) got Vesugen courses. Angiograms showed 20-30% better vessel openness—peptide normalized endothelium (vessel lining cells), reducing plaques like scraping rust off pipes. Angina attacks dropped 70%, exercise tolerance up (walk farther without huffing). It ramps nitric oxide for dilation and cuts inflammation. Safe add-on to statins. Clinical edge: prevents bypasses, energizes seniors. Cycles restore vessel youth.

Read the study ↗

Short peptide

More references (7)

Identification

Chemistry

common names
Vesugen, Vesugen KED, KED tripeptide, Lys-Glu-Asp, lysyl-glutamyl-aspartic acid, lysylglutamylaspartic acid, L-lysyl-L-glutamyl-L-aspartic acid, tripeptide bioregulator
cas
Not assigned (N/A); no official CAS registry number formally designated
formula
C₁₅H₂₆N₄O₈
molecular weight
390.39 Da or g/mol
source
Synthetic; not naturally occurring as isolated tripeptide, though represents combination of amino acids present in vascular wall proteins and collagen
biosynthesis
Nonribosomal; synthesized via solid-phase peptide synthesis (SPPS) from purified L-lysine, L-glutamic acid, and L-aspartic acid monomers
type
Linear tripeptide with:

Keep exploring

Related peptides

Educational use only. The protocols shown summarise published research and community practice for informational purposes. They are not medical advice, not a prescription, and not a recommendation to use any compound. Research peptides are generally not approved for human use. Consult a licensed clinician. Full disclaimer.
Ask the advisor